KZA kazia therapeutics limited
Add to My Watchlist 0.00% ! 8.0¢

Ann: GDC 0084 progress update, page-4

  1. Merchant2000
    24,988 Posts.
    lightbulb Created with Sketch. 985
    clock Created with Sketch.
    22/08/17
    09:53
    Post #: 26652846
    Hopefully soon they will announce the financial details of the MSA

    Novogen has signed a Master Services Agreement (MSA) with Chiltern Oncology in relation to conduct of the phase II clinical trial of GDC-0084.

    Chiltern Oncology is a leading international contract research organization, with a specialist capability in trials of novel anti-cancer agents.

    The MSA details key terms of the proposed working relationship, but implementation of the study will be subject to further contractual negotiations.
    Last edited by Merchant2000: 22/08/17
    NRT Price at posting: 4.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS High-Grade Niobium Intercept Delivered by Initial Drilling at Joyce
right-arrow Created with Sketch.
NEWS MTM Successful Uplisting Commences Trading on OTCQX Market in US
right-arrow Created with Sketch.
NEWS Next Science to Sell Majority of Assets in Proposed Transaction
right-arrow Created with Sketch.
NEWS Austral Resources to Acquire Rocklands to Transform North-West Queensland Copper
right-arrow Created with Sketch.
NEWS More Outstanding Gallium Assay Results for Nimy at Block 3
right-arrow Created with Sketch.
NEWS Drilling Commences at Leinster South Project in WA
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.